eIF4G2-dependent translation restrains pancreatic cancer progression
James M. Powers, Wei Lai, Justin Chak Ting Cheung, Pardis Ahmadi, Hiroki Kobayashi, Álvaro Curiel‐García, Stella Kang, Elizabeth Valenzuela, Marko Jovanović, Alejandro Chavez, Iok In Christine Chio
This study identifies eIF4G2 as a translational checkpoint that restricts pancreatic cancer progression by maintaining epithelial identity and limiting metastasis.
Cancer Research · May 27, 2026Peer-reviewedCancer Biology